Post-translational modification regulates prostaglandin D2 synthase apoptotic activity: Characterization by site-directed mutagenesis

Prostaglandins and Other Lipid Mediators

Volumn 83, Issue 1-2, 2007, Pages 25-32

  Ragolia, Louis ^a,b   Hall, Christopher E ^a   Palaia, Thomas ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Apoptosis; Glycosylation; Prostaglandins; VSMC

Indexed keywords

ASPARAGINE; CASPASE 3; CYSTEINE; ISOENZYME; LIPOCALIN; PROSTAGLANDIN D SYNTHASE; PROSTAGLANDIN D2 SYNTHASE; PROTEIN KINASE C; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BODY FLUID; CELL PROLIFERATION; CELL TYPE; DIABETES MELLITUS; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; GLYCOLYSIS; HYPERTENSION; KIDNEY DYSFUNCTION; MALE; MUTATION; NERVE CELL; NICK END LABELING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; POINT MUTATION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; RAT; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS; SMOOTH MUSCLE FIBER; TWO DIMENSIONAL GEL ELECTROPHORESIS; VASCULAR SMOOTH MUSCLE;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL PROLIFERATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GLUCOSE; HUMANS; HYPERGLYCEMIA; INTRAMOLECULAR OXIDOREDUCTASES; ISOENZYMES; MALE; MOLECULAR SEQUENCE DATA; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS, SITE-DIRECTED; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, WISTAR;

EID: 33846438639     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2006.09.006     Document Type: Article

References (28)

1. Urade Y., and Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm 58 (2000) 89-120
2. Hiraoka A., Seiki K., Oda H., et al. Charge microheterogeneity of the beta-trace proteins (lipocalin-type prostaglandin D synthase) in the cerebrospinal fluid of patients with neurological disorders analyzed by capillary isoelectrofocusing. Electrophoresis 22 16 (2001) 3433-3437
3. 2 synthase and its post-translational modifications in neurological disorders. Electrophoresis 26 23 (2005) 4563-4570
4. Melegos D.N., Freedman M.S., and Diamandis E.P. Prostaglandin D synthase concentration in cerebrospinal fluid and serum of patients with neurological disorders. Prostaglandins 54 1 (1997) 463-474
5. Inoue T., Takayanagi K., Morooka S., et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Thromb Haemost 85 1 (2001) 165-170
6. Hirawa N., Uehara Y., Ikeda T., et al. Urinary prostaglandin D synthase (beta-trace) excretion increases in the early stage of diabetes mellitus. Nephron 87 4 (2001) 321-327
7. Eguchi Y., Eguchi N., Oda H., et al. Expression of lipocalin-type prostaglandin D synthase (beta-trace) in human heart and its accumulation in the coronary circulation of angina patients. Proc Natl Acad Sci USA 94 26 (1997) 14689-14694
8. Hirawa N., Uehara Y., Yamakado M., et al. Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension 39 2 Pt 2 (2002) 449-454
9. Rogers M.S., Rohan R.M., Birsner A.E., and D'Amato R.J. Genetic loci that control vascular endothelial growth factor-induced angiogenesis. Faseb J 17 14 (2003) 2112-2114
10. Taba Y., Sasaguri T., Miyagi M., et al. Fluid shear stress induces lipocalin-type prostaglandin D(2) synthase expression in vascular endothelial cells. Circ Res 86 9 (2000) 967-973
11. 2 as a mediator of allergic asthma. Science 287 5460 (2000) 2013-2017
12. 2 relaxes bovine coronary arteries by endothelium-dependent nitric oxide-mediated cGMP formation. Circ Res 71 6 (1992) 1305-1313
13. Eguchi N., Minami T., Shirafuji N., et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc Natl Acad Sci USA 96 2 (1999) 726-730
14. 2 on platelet aggregation in different species. Prostaglandins 16 3 (1978) 373-388
15. 2 synthase knock-out mice. J Biol Chem 280 33 (2005) 29946-29955
16. 2 synthase inhibits the exaggerated growth phenotype of spontaneously hypertensive rat vascular smooth muscle cells. J Biol Chem 278 24 (2003) 22175-22181
17. Ragolia L., Palaia T., Paric E., and Maesaka J.K. Elevated L-PGDS activity contributes to PMA-induced apoptosis concomitant with downregulation of PI3-K. Am J Physiol Cell Physiol 284 1 (2003) C119-C126
18. 2 synthase: resistance in diabetic Goto-Kakizaki rats. Am J Physiol Cell Physiol 287 5 (2004) C1273-C1281
19. Ragolia L., and Begum N. The effect of modulating the glycogen-associated regulatory subunit of protein phosphatase-1 on insulin action in rat skeletal muscle cells. Endocrinology 138 6 (1997) 2398-2404
20. Maesaka J.K., Palaia T., Frese L., Fishbane S., and Ragolia L. Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells. Kidney Int 60 5 (2001) 1692-1698
21. 2 synthase induces apoptosis in PC12 neuronal cells. Neuroreport 12 12 (2001) 2623-2628
22. Smith P.K., Krohn R.I., Hermanson G.T., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 1 (1985) 76-85
23. Puchades M., Hansson S.F., Nilsson C.L., Andreasen N., Blennow K., and Davidsson P. Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer's disease. Brain Res Mol Brain Res 118 1/2 (2003) 140-146
24. Parry S., Hadaschik D., Blancher C., et al. Glycomics investigation into insulin action. Biochim Biophys Acta 1760 4 (2006) 652-668
25. Cohen-Forterre L., Andre J., Mozere G., Peyroux J., and Sternberg M. Kidney sialidase and sialyltransferase activities in spontaneously and experimentally diabetic rats. Influence of insulin and sorbinil treatments. Biochem Pharmacol 40 3 (1990) 507-513
26. Rellier N., Ruggiero-Lopez D., Lecomte M., Lagarde M., and Wiernsperger N. In vitro and in vivo alterations of enzymatic glycosylation in diabetes. Life Sci 64 17 (1999) 1571-1583
27. Wiese T.J., Dunlap J.A., and Yorek M.A. Effect of l-fucose and d-glucose concentration on l-fucoprotein metabolism in human Hep G2 cells and changes in fucosyltransferase and alpha-l-fucosidase activity in liver of diabetic rats. Biochim Biophys Acta 1335 1/2 (1997) 61-72
28. Fujimori K., Kadoyama K., and Urade Y. Protein kinase C activates human lipocalin-type prostaglandin D synthase gene expression through de-repression of notch-HES signaling and enhancement of AP-2 beta function in brain-derived TE671 cells. J Biol Chem 280 18 (2005) 18452-18461